Anti-proliferation and anti-invasion effects of diosgenin on gastric cancer BGC-823 cells with HIF-1α shRNAS

International Journal of Molecular Sciences

Volumn 13, Issue 5, 2012, Pages 6521-6533

  Mao, Zhu Jun ^a   Tang, Qian Jue ^a   Zhang, Ci An ^b   Qin, Zhi Feng ^b   Pang, Bin ^c   Wei, Pin Kang ^a   Liu, Bo ^d   Chou, Yuan Neng ^e  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Air Force Center of Aviation Medical Evaluation and Training   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Diosgenin; Gastric cancer; HIF 1 ; Hypoxia; shRNA

Indexed keywords

ALPHA5 INTEGRIN; BETA6 INTEGRIN; COBALT CHLORIDE; DIOSGENIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SHORT HAIRPIN RNA; UVOMORULIN; BETA INTEGRIN; CADHERIN; COBALT; HIF1A PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROENVIRONMENT; SOLID TUMOR; STOMACH CANCER; CELL HYPOXIA; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

CADHERINS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COBALT; DIOSGENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTEGRIN ALPHA5; INTEGRIN BETA CHAINS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 84861534971     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13056521     Document Type: Article

References (41)

1. Lin, X.; Zhang, D.; Du, R.; Pan, Y.; Zhao, L.; Sun, S.; Hong, L.; Fan, D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 2008, 123, 372-379.
2. Urano, N.; Fujiwara, Y.; Doki, Y.; Kim, S.J.; Miyoshi, Y.; Noguchi, S.; Miyata, H.; Takiguchi, S.; Yasuda, T.; Yano, M.; et al. Clinical significance of class III β-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer. Int. J. Oncol. 2006, 28, 375-381.
3. Dean, M.; Fojo, T.; Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5, 275-284.
4. Casanovas, O.; Daniel, J.; Bergers, G.; Hanahan, D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005, 8, 299-309.
5. Siegfried, J.A.; Kennedy, K.A. The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells. J. Biol. Chem. 1983, 258, 339-343.
6. Katrina, M.; Comerford, T.; Wallace, J. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002, 62, 3387-3394.
7. Xu, R.-H.; Pelicano, H. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005, 65, 613-621.
8. Huang, L.E.; Arany, Z.; Livingston, D.M.; Bunn, H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem. 1996, 271, 32253-32259.
9. Krieg, M.; Haas, R.; Brauch, H.; Acker, T.; Flamme, I.; Plate, K.H. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000, 19, 5435-5443.
10. Jones, N.M.; Lee, E.M. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1α (HIF-1α) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain. Neurosci. Lett. 2006, 404, 72-77.
11. Talks, K.L.; Turley, H.; Gatter, K.C.; Maxwell, P.H.; Pugh, C.W.; Ratcliffe, P.J.; Harris, A.L. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 2000, 157, 411-421.
12. Zhong, H.; de Marzo, A.M. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 1999, 59, 5830-5835.
13. Zhou, J.; Schmid, T. Tumor hypoxia and cancer progression. Cancer Lett. 2006, 237, 10-21.
14. Liu, L.; Ning, X. Hypoxia-inducible factor-1 contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci. 2008, 99, 121-128.
15. Giaccia, A.; Siim, B.G.; Johnson, R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2003, 2, 803-811.
16. Sautour, M.; Mitaine-Offer, A.C.; Miyamoto, T.; Dongmo, A.; Lacaille-Dubois, M.A. A new steroidal saponin from Dioscorea cayenensis. Chem. Pharm. Bull. (Tokyo) 2004, 52, 1353-1355.
17. Daisy, P.; Eliza, J. Influence of Costus speciosus (Koen.) Sm. Rhizome extracts on biochemical parameters in streptozotocin induced diabetic rats. J. Health Sci. 2008, 54, 675-681.
18. Raju, J.; Bird, R.P. Diosgenin, a naturally occurring steroid [corrected] saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett. 2007, 55, 194-204.
19. Jeon, J.R.; Lee, J.S.; Lee, C.H.; Kim, J.Y.; Kim, S.D.; Nam, D.H. Effect of ethanol extract of dried Chinese yam (Dioscorea batatas) flour containing dioscin on gastrointestinal function in rat model. Arch. Pharm. Res. 2006, 29, 348-353.
20. Son, I.S.; Kim, J.H.; Shon, H.Y.; Son, K.H.; Kim, J.S.; Kwon, C.S. Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci. Biotechnol. Biochem. 2007, 71, 3063-3071.
21. Lee, J.; Jung, K.; Kim, Y.S. Diosgenin inhibits melanogenesis through the activation of hosphatidylinositol-3-kinase pathway (PI3K) signaling. Life Sci. 2007, 81, 249-254.
22. Kang, W.H.; Yoon, K.H.; Lee, E.S.; Kim, J.; Lee, K.B.; Yim, H.; Sohn, S.; Im, S. Histopathalogical characteristics in 56 Korean patients. Br. J. Dermatol. 2002, 146, 228-237.
23. Li, J.; Liu, X.; Guo, M.; Liu, Y.; Liu, S.; Liu, S.; Yao, S. Electrochemical study of breast cancer cells MCF-7 and its application in evaluating the effect of diosgenin. Anal. Sci. 2005, 21, 561-564.
24. Raju, J.; Bird, R.P. Diosgenin, a naturally occurring furostanol saponin suppresses 3-hydroxy-3-m ethylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett. 2007, 255, 194-204.
25. Moalic, S.; Liagre, B.; Corbiere, C.; Bianchi, A.; Dauca, M.; Bordji, K.; Beneytout, J.L. A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Lett. 2001, 506, 225-230.
26. Rohwer, N.; Welzel, M.; Daskalow, K.; Pfander, D.; Wiedenmann, B.; Detjen, K.; Cramer, T. Hypoxia-inducible factor 1α mediates anoikis resistance via suppression of α5 integrin. Cancer Res. 2008, 68, 10113-10118.
27. Liu, L.; Ning, X.X. Hypoxia-inducible factor-1 contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci. 2008, 99, 121-128.
28. Greco, O.; Marpels, B.; Joiner, M.C.; Scott, S.D. How to overcome (and exploit) tumor hypoxia for targeted gene therapy. J. Cell Physiol. 2003, 197, 312-325.
29. Durand, R.E. Keynote address: The influence of microenvironmental factors on the activity of radiation and drugs. Int. J. Radiat. Oncol. Biol. Phys. 1991, 20, 253-258.
30. Hockel, M.; Vaupel, P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 2001, 93, 266-276.
31. Greijer, A.E.; de Jong, M.C.; Scheffer, G.L.; Shvarts, A.; van Diest, P.J.; van der wall, E. Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells. Cell. Oncol. 2005, 27, 43-49.
32. Matthews, N.E.; Adams, M.A.; Maxwell, L.R.; Gofton, T.E.; Graham, C.H. Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J. Natl. Cancer Inst. 2001, 93, 1879-1885.
33. Flamant, L.; Notte, A.; Ninane, N.; Raes, M.; Michiels, C. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol. Cancer 2010, 9, doi:10.1186/1476-4598-9-191.
34. Griffiths, E.A.; Pritchard, S.A.; Welch, I.M.; Price, P.M.; West, C.M. Is the hypoxia-inducible factor pathway important in gastric cancer? Eur. J. Cancer 2005, 41, 2792-2805.
35. Takeshita, F.; Ochiya, T. Therapeutic potential of RNA interference against cancer. Cancer Sci. 2006, 97, 689-696.
36. Dame, C.; Haugstetter, A.; Rohwer, N.; Wiedenmann, B.; Detjen, K.; Schmitt, C.A.; Cramer, T. Hypoxia-inducible factor 1α determines gastric cancer chemosensitivity via modulation of p53 and NF-kB. PLoS One 2010, 5, doi:10.1371/journal.pone.0012038.
37. Murthy, N.S.; Mukherjee, S.; Ray, G.; Ray, A. Dietary factors and cancer chemoprevention: An overview of obesity-related malignancies. J. Postgrad. Med. 2009, 55, 45-54.
38. Berx, G.; Cleton-Jansen, A.M.; Nollet, F.; de Leeuw, W.J.; van de Vijver, M.; Cornelisse, C.; van Roy, F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995, 14, 6107-6115.
39. Wong, A.S.; Gumbiner, B.M. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J. Cell Biol. 2003, 161, 1191-1203.
40. Zutter, M.M.; Mazoujian, G.; Santoro, S.A. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am. J. Pathol. 1990, 137, 863-870.
41. Ramos, D.M.; But, M.; Regezi, J.; Schmidt, B.L.; Atakilit, A.; Dang, D.; Ellis, D.; Jordan, R.; Li, X. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma. Matrix Biol. 2002, 21, 297-307.